GOVERNANCE WATCH
By InsidEntity Editorial Desk · Jul 26, 2026 · 8 min read
Run Enron’s board through the InsidEntity Company Risk Rating using only the classifications in the company’s own 2001 proxy statement, and the result is unremarkable: a rating of 3.1, Good, indistinguishable from the hundreds of newly listed boards this platform scores every year under the same default assumption of good faith. Verify the same filing against the methodology’s own tests (a ten-year tenure rule, a check for disclosed business relationships, a check for subsidiary chairmanships sitting on the parent board), and the rating falls to 2.25, Caution. Nothing in the underlying facts changed between those two numbers. Only the verification did.
That gap is exactly what InsidEntity’s framework exists to test, and Enron is the company every governance discussion eventually reaches. This is a retrospective exercise, not a live rating: Enron Corp. has not existed as an operating company since 2001, and nothing here claims the platform would have predicted the collapse. What it tests is narrower. Using only information filed with the SEC before Enron collapsed, what would this methodology have concluded, and how much of the difference between the wrong answer and the right one came from information nobody had versus information nobody checked?
Methodological note: this retrospective uses only information publicly available before Enron entered bankruptcy. Later investigations, including the Senate PSI report, are cited only where they corroborate facts already disclosed in Enron’s own public filings or document governance decisions the board made before the company’s collapse. Director Independence is assessed using InsidEntity’s published methodology: tenure against a ten-year threshold, disclosed business relationships, and disclosed governance roles.
The first read: Enron’s own classifications
Fourteen directors stood for election at Enron’s 2001 annual meeting. Two, Kenneth Lay and Jeffrey Skilling, were executives and count toward no independence pillar under any framework. Taking the board’s own classification of the remaining twelve non-executive directors at face value, the pillars land as follows.
| Component | Score | Read |
|---|---|---|
| Director Independence | 5.0 | Benchmark, by default: the platform’s standard assumption before independence is independently verified |
| Shareholder Influence | 5.0 | Benchmark: Enron’s shares were widely held, no holder near the 20% threshold |
| Director Capacity | 2.75 | Caution-adjacent, based on outside directorships disclosed in the same proxy |
| Auditor Independence | 0.0 | Nil |
| Overall Rating | 3.1 | Good |
(1 Risk, 2 Caution, 3 Good, 4 Excellent, 5 Benchmark, per InsidEntity’s Company Risk Rating methodology. The overall rating is the average of the four pillar scores: (5.0 + 5.0 + 2.75 + 0.0) ÷ 4 = 3.1.)
If this platform had stopped there, it would have produced the wrong answer: the same default every unverified board on the platform carries today.
The board, verified against its own filing
| Director | Director since | Tenure by 2001 | Background |
|---|---|---|---|
| Robert Belfer | 1983 | 18 years | Chairman/CEO, Belco Oil & Gas; formerly President and Chairman of Belco Petroleum, a former Enron subsidiary |
| John Duncan | 1985 | 16 years | Private investor since 1990 |
| Robert Jaedicke | 1985 | 16 years | Professor Emeritus of Accounting, Stanford Graduate School of Business |
| Charles LeMaistre | 1985 | 16 years | Former President, University of Texas M.D. Anderson Cancer Center |
| Herbert Winokur | 1985 | 16 years | Chairman/CEO, Capricorn Holdings; non-executive Chairman of Azurix Corp, an Enron-controlled subsidiary, August 2000–March 2001, while sitting on Enron’s own board |
| John Wakeham (Lord Wakeham) | 1994 | 7 years | Former UK Secretary of State for Energy; separately paid as a consultant to Enron |
| Wendy Gramm | 1993 | 8 years | Economist; former Chairman, US Commodity Futures Trading Commission |
| Norman Blake | 1993 | 8 years | Chairman/President/CEO, Comdisco Inc. |
| Ronnie Chan | 1996 | 5 years | Chairman, Hang Lung Group |
| John Mendelsohn | 1999 | 2 years | President, University of Texas M.D. Anderson Cancer Center |
| Paulo Ferraz Pereira | 1999 | 2 years | EVP, Group Bozano |
| Frank Savage | 1999 | 2 years | Chairman, Alliance Capital Management International |
Source: Enron Corp. Form DEF 14A, filed with the SEC for the 2001 annual meeting.
Tenure: five of twelve, before a single conflict is examined. InsidEntity’s Director Independence pillar applies a ten-year tenure cutoff, the same rule this series has applied at AMD (Ernst & Young since 1969, nil on the auditor pillar) and Alphabet (EY since before the 2004 IPO, nil). Belfer, Duncan, Jaedicke, LeMaistre and Winokur, all seated in Enron’s founding-era cohort of 1983–1985, had each passed sixteen years or more by 2001. On tenure alone, five of twelve would not qualify as independent under InsidEntity’s methodology.
A consulting fee inside the Audit Committee. A sixth director fails a different test. The US Senate Permanent Subcommittee on Investigations’ July 2002 report, The Role of the Board of Directors in Enron’s Collapse, found that Lord Wakeham was paid approximately $6,000 a month as a consultant to Enron, alongside his director’s fees, for years overlapping his board service. The same proxy that disclosed the arrangement placed Wakeham on the Audit Committee, described in Enron’s own filings as “the primary liaison with Andersen.” A director paid by the company he is meant to oversee, sitting on the committee responsible for policing the auditor relationship, is not a peripheral conflict. It is a structural compromise of the oversight mechanism itself, and it was disclosed, not discovered.
A subsidiary chairmanship on the parent board. Winokur’s case is different in kind, same in principle: a sitting Enron director who simultaneously chaired the board of Azurix, a majority Enron-owned subsidiary, for seven months in 2000–2001. A director cannot meaningfully oversee a parent company’s related-party dealings while chairing one of its own subsidiaries; the role itself is the conflict, and it too was disclosed in Enron’s own proxy.
A waiver the composition score was never built to catch. Separately, and distinct from board composition: Enron’s board approved a waiver of the company’s own Code of Conduct of Business Ethics in June 1999, ratifying a determination that CFO Andrew Fastow’s participation in the related-party partnership LJM1 “will not adversely affect the interests of the company,” per the Senate PSI report. The board ratified the same determination again in October 1999 for LJM2, after Winokur presented the proposal to the full board on October 11. LJM1 and LJM2 became the vehicles through which billions in debt and losses were kept off Enron’s own books, debt that resurfaced in the November 2001 restatement, which added roughly $2.6 billion back onto Enron’s balance sheet alongside a $586 million cut to previously reported net income. That decision is a governance choice a board made, not a structural fact about who sat where. A composition pillar can score whether a board is independent. It cannot score what an independent board chooses to approve.
The corrected scorecard
| Component | Initial Score | Verified Score | Basis |
|---|---|---|---|
| Director Independence | 5.0 | 1.75 | Five of twelve directors past the ten-year line; a sixth with a disclosed consulting fee running alongside Audit Committee service; a seventh chairing a subsidiary board while serving on the parent’s |
| Shareholder Influence | 5.0 | 5.0 | Correct as scored: shares were widely held, no holder near the 20% threshold |
| Director Capacity | 2.75 | 2.0 | The Senate PSI found Enron’s Audit Committee met for strikingly little time relative to the complexity of what it approved; several directors also carried substantial outside board commitments |
| Auditor Independence | 0.0 | 0.0 | Arthur Andersen served as Enron’s auditor since the 1980s while earning $25 million in audit fees and $27 million in non-audit consulting fees from the company in 2000 alone |
| Overall Rating | 3.1 | 2.25 |
(1 Risk, 2 Caution, 3 Good, 4 Excellent, 5 Benchmark. (1.75 + 5.0 + 2.0 + 0.0) ÷ 4 = 2.25, Caution.)
The methodology did not change. The facts did not change. Only the verification changed, and the gap between 3.1 and 2.25 is not a modelling error. It is the completed questionnaire.
What the other two instruments would, and would not, have shown
The Health Status Rating depends on the company telling the truth. HSR asks companies to self-disclose against specific triggers each quarter, among them financial distress and fraud by top management. Enron’s actual 2001 would have tripped several of those in real time: Skilling’s abrupt August resignation, the SEC inquiry opened in October, the November restatement, and Fastow’s removal as CFO that same month. But HSR is only as reliable as the company answering it, and a board that had already voted to waive its own conduct code to permit the arrangement in question was not a board likely to volunteer that it was failing. HSR would plausibly have caught the collapse in its final quarter, once outside forces made concealment impossible. It would not have caught the years before.
The Financial Viability Rating reads reported numbers, and Enron’s reported numbers were the fraud. FVR is built on a company’s own consolidated financial statements. Enron’s reported statements were themselves the misrepresentation; the restated figures only existed because outside pressure forced them into the open. A ratio-based rating cannot outperform the honesty of the figures it is given. That is not a flaw unique to FVR; it is the reason InsidEntity runs three separate instruments rather than one, and the reason none of the three is ever described as sufficient alone.
Reading the two ratings together
None of this proves InsidEntity’s methodology would have flagged Enron before anyone else did. Every new company on this platform starts exactly where Enron’s board started: unverified, at the benchmark default. What this exercise shows is narrower and more useful: the facts needed to move Enron off that default were sitting in a public proxy statement in 2001, available to anyone who checked tenure against a ten-year rule and cross-referenced disclosed consulting arrangements and subsidiary chairmanships against the parent board’s own roster. Nobody needed hindsight. They needed the questionnaire completed, and someone willing to read the answer.
A proxy statement tells you what a company discloses.
Verification tells you whether the disclosure would have survived scrutiny.
About the InsidEntity Company Risk Rating
The InsidEntity Company Risk Rating (CRR) scores companies on a 1 to 5 scale across four governance pillars, weighted 40/20/20/20: Director Independence, Director Capacity, Auditor Independence, and Shareholder Influence. A 5 is Benchmark, a 1 is Risk, and Director Independence carries the heaviest weight, so a weakness there shows up fastest in the headline number. For more on how the score is built, see our Company Risk Rating methodology. Ratings update regularly as board, auditor, and shareholder changes occur. Explore ratings for companies across 145 stock exchanges at InsidEntity.
Know your entity. This retrospective analysis applies InsidEntity’s current methodology to historical, publicly filed facts for illustrative purposes only; it is not a live company rating, and Enron Corp. has not existed as an operating company since 2001. Figures are drawn from Enron’s 2001 SEC Form DEF 14A and the US Senate Permanent Subcommittee on Investigations’ July 2002 report, as cited. This is independent research, not financial advice.